20876-30-6

Basic information

• Product Name: (4-METHOXY-2-NITRO-PHENYL)-ACETIC ACID
• Synonyms: (4-METHOXY-2-NITRO-PHENYL)-ACETIC ACID;(2-Nitro-4-Methoxyphenyl)acetic acid;4-Methoxy-2-nitro-benzeneacetic acid;2-(4-Methoxy-2-nitrophenyl)acetic acid
• CAS NO: 20876-30-6
• Molecular Formula: C₉H₉NO₅
• Molecular Weight: 211.17
• Mol File: 20876-30-6.mol

Chemical Properties

• Boiling Point: 396 °C at 760 mmHg
• Flash Point: 193.3 °C
• Appearance: /
• Density: 1.382 g/cm³
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: (4-METHOXY-2-NITRO-PHENYL)-ACETIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: (4-METHOXY-2-NITRO-PHENYL)-ACETIC ACID(20876-30-6)
• EPA Substance Registry System: (4-METHOXY-2-NITRO-PHENYL)-ACETIC ACID(20876-30-6)

Safety Data

• Hazardous Substances Data: 20876-30-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(4-METHOXY-2-NITRO-PHENYL)-ACETIC ACID is used as an intermediate in the synthesis of pharmaceutical compounds for its anti-inflammatory and analgesic properties. It serves as a key component in the development of new drugs that aim to provide effective pain relief and treat inflammation.
Used in Chemical Industry:
In the chemical industry, (4-METHOXY-2-NITRO-PHENYL)-ACETIC ACID is used as an intermediate for the production of various organic compounds. Its unique chemical structure, featuring a nitro and methoxy group, makes it a valuable compound for further research and potential applications in the synthesis of specialty chemicals and materials.

Upstream product

• 65547-98-0 ethyl 2-cyano-2-(4-methoxy-2-nitrophenyl)acetate 
• 10565-15-8 diethyl 2-(4-methoxy-2-nitrophenyl)malonate 
• 17484-36-5 4-Methyl-3-nitroanisole 
• 2042-14-0 4-methyl-5-nitrophenol 
• 10298-80-3 2-chloro-5-methoxynitrobenzene 
• 105003-90-5 (4-methoxy-2-nitro-phenyl)-acetonitrile 
• 16792-46-4 (4-methoxy-2-nitro-phenyl)-pyruvic acid 
• 7722-84-1 dihydrogen peroxide 
• 95-92-1 oxalic acid diethyl ester 

Downstream Products

• 1196872-67-9 tert-butyl (4-methoxy-2-nitrophenyl)acetate 
• 1050514-12-9 2-(4-methoxy-2-nitrophenyl)ethylmethylsulfone 
• 1050514-03-8 4-methoxy-1-(2-methoxyethyl)-2-nitrobenzene 
• 1050514-11-8 4-methoxy-1-[2-(methylthio)ethyl]-2-nitrobenzene 
• 1050514-10-7 1-(2-bromoethyl)-4-methoxy-2-nitrobenzene 
• 90923-03-8 (4-methoxy-2-nitro-phenyl)-acetic acid methyl ester 
• 1334784-90-5 (2-acetylamino-4-methoxy-phenyl)-acetic acid 
• 1334784-89-2 (2-acetylamino-4-methoxy-phenyl)-acetic acid methyl ester 
• 1050514-02-7 2-(4-methoxy-2-nitrophenyl)ethanol 
• 7699-19-6 6-methoxyoxindole 
• 109932-73-2 6,7-dimethoxy-1-(4-methoxy-2-nitro-benzyl)-3,4-dihydro-isoquinoline 
• 746621-69-2 3-(4-methoxy-2-nitro-phenyl)-7-(2-piperidin-1-yl-ethoxy)-chromen-4-one 
• 332150-59-1 7-hydroxy-3-(4-methoxy-2-nitro-phenyl)-chromen-4-one 
• 332150-57-9 1-(2,4-dihydroxy-phenyl)-2-(4-methoxy-2-nitro-phenyl)-ethanone 

Relevant articles and documents

2,3-DIHYDRO-1H-INDEN-1-YL-2,7-DIAZASPIRO[3.5] NONANE DERIVATIVES

The present invention provides a compound of Formula (I) or a pharmaceutically salt thereof wherein R1, R2, Ra, L, Z, Z1 and Z2 are as defined herein, that act as Ghrelin antagonists or inverse agonists; pharmaceutical compositions thereof; and methods of treating diseases, disorders, or conditions mediated by the antagonism of the Ghrelin receptor.

Wavelength-selective photoactivatable protecting groups for thiols

We developed and characterized efficient, remarkably water-soluble photolabile protecting groups for thiols based on 2-nitrobenzyl and (coumarin-4-yl)methyl chromophores, among them two new ones. The protecting groups allow, due to their different absorpt

QUINOXALINE COMPOUNDS AND USE THEREOF

The present invention is related to quinoxaline compounds of Formula (I) in particular for the treatment of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.

An aminoisoflavone-salicyloylindole ring transformation

A series of 2′-nitroisoflavones 8-10, 15, 22, 27 and 28 was prepared via the (2-nitro-phenyl)-acetic acids 1, 13, 19 and 25. In order to obtain the corresponding 2′-aminoisoflavones the reduction of 8-10, 15, 22, 27 and 28 was undertaken. Surprisingly, new 3-salicyloylindoles instead of the expected 2′-aminoisoflavones were the main reduction products. In the following paper the preparation of the 2′-nitroisoflavones 8-10, 15, 22, 27 and 28 as well as the reduction experiments obtaining the 2′-aminoisoflavones 33 and 35 and the 3-salicyloylindoles 29-32, 34 and 36 will be described. Furthermore, a possible mechanism responsible for the formation of the 3-salicyloylindoles from 2′-nitroisoflavones under reductive conditions will be discussed.

Hexahydro-cyclohepta-pyrrole oxindole as potent kinase inhibitors

The present invention is directed to a class indolinone compounds, hexahydro-cyclohepta-pyrrole oxindoles, which are useful as protein kinase inhibitors.